Noema Pharma raised €105M in a Series B round in Mar 2023. The company is based in Basel, Switzerland. Investors in the round: Forbion, Gilde Healthcare, Invus and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
